Trial intelligence / Profile preview

Triptorelin for prevention of chemotherapy-induced ovarian failure in young women with breast cancer

ChiCTR-TRC-10000980Phase 2Recruiting

Sponsor
Sun Yat-sen Memorial Hospital
Start
Jan 2008
Modality
Small Molecules, Peptides
Countries
1
01

Overview

Phase 2, randomised trial in breast cancer comparing Placebo control group with Triptorelin group (2 arms). Primary endpoint: Ovarian reserve at 6 months after chemotherapy. Started Jan 2008; status: recruiting.

02

Drugs

triptorelin
03

Conditions

breast cancer

Beyond the preview

Go deeper on ChiCTR-TRC-10000980.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-10000980.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call